Cerecor Announces Expansion of Leadership Team New

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
48
Cerecor Announces Expansion of Leadership Team

New Leadership Supports Company Evolution into Innovative Specialty Pharmaceutical Company

BALTIMORE, July 16, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC ), today announced executive management changes that continue the Company’s strategic shift and further align its organizational structure to its long-term strategy.  Specifically, effective today, the Company announced the appointment of Joe Miller as Chief Financial Officer, Dr. Pericles Calias as Chief Scientific Officer and Jamie Harrell as Executive Vice President of Marketing and Investor Relations.  Mariam Morris will be stepping down immediately from her position as Chief Financial Officer and will remain on for a period of time as a consultant to aid the Company during the transition.

Peter Greenleaf, Chief Executive Officer of Cerecor, commented, " We are excited to have recruited such talent and experience to help drive growth, lead organizational transformation and accelerate our innovative pipeline. We have pivoted the organization from an early stage research and development shop to a fully integrated specialty pharmaceutical company.  The addition of these experienced and tested biopharmaceutical leaders, positions Cerecor for continued execution on its mission to become an innovative pediatric specialty pharmaceutical company.  I’d also like to extend my appreciation and gratitude to Ms. Mariam Morris for her service to the organization.  Mariam was a key driver of the Cerecor IPO and helped close our last two business development and licensing deals.” 

Mr. Joe Miller, CPA, brings over 20 years of experience and a wealth of financial knowledge as a senior executive with extensive hands-on experience in managing financial operations and supporting enterprise growth across the health sciences, bio-tech and pharmaceutical sectors.  In his previous role at Sucampo Pharmaceuticals, he was responsible for building out of the finance organization to effectively support the company’s rapid growth, ultimately resulting in the $1.2B merger with Mallinckrodt in early 2018.  Prior to Sucampo, he served in various progressive finance and management roles at Qiagen, Eppendorf and KPMG LLP.  Mr. Miller’s strengths include leading and building out company finance infrastructure and creating scalable, world-class organizations, making him an excellent fit into the strategic imperatives of growth and innovation at the new Cerecor.  Mr. Miller holds a B.S. degree in accounting from Villanova University and is a Certified Public Accountant.

Dr. Perry Calias, Ph.D., brings over 25 years of biopharmaceutical experience in clinical development across the drug and device sectors of healthcare. His strengths include pre-clinical, clinical development and global regulatory submissions.  Dr. Calias has extensive experience in CNS and Neurology as well as Rare Diseases.  He has a strong track record in compound development and pipeline progression, as well as building research and development organizations.   His previous experience includes serving as Vice President of Global CMC and Product Development at Sucampo.  He has held a variety of research and development positions both in clinical and non-clinical roles of expanded leadership at Shire HGT and Genzyme.  Dr. Calias’ strong background in early stage asset development, as well as his clinical trial experience, add to the Cerecor clinical organization as we enter into our Phase 1 trials of two of our Neurology assets.  Dr. Calias obtained his Ph.D. in Organic Chemistry from Tufts University and his B.S. in biology from Suffolk University.

Mr. James Harrell, with over 25 years of biopharmaceutical experience, brings a breadth of commercial and marketing success to the organization.  Mr. Harrell has held the positions of Vice President and General Manager of Specialty Pharmaceuticals for Covidien, running a 350-person commercial operations group.  Additionally, he has held various commercial and leadership positions throughout his career in executive management, marketing and sales with organizations such as Covidien, Medimmune, Centocor, Inc. and Rhone Poulenc Rorer.  Throughout his career, he helped to commercialize and market over 25 products, including the three blockbuster drugs, Lovenox®, Remicade® and Synagis®, each achieving over $1 Billion in annual US sales. He holds a B.S. degree in Business Administration, with a double major in Marketing and Economics, from Samford University.

About Cerecor

Cerecor is a biopharmaceutical company focused on the goal of becoming the leading U.S. pediatric pharmaceutical company while developing innovative therapies that make a difference in the lives of patients. The Company’s pipeline is led by CERC-301, which Cerecor currently intends to explore as a novel treatment for orphan neurologic indications. Cerecor is also developing two pre-clinical stage compounds, CERC-611 and CERC-406. The Company’s R&D efforts are supported by profits from its franchise of commercial medications led by Poly-Vi-Flor ® (multivitamin and fluoride supplement tablet, chewable) and Tri-Vi-Flor ® (multivitamin and fluoride supplement suspension/drops). In February 2018, the Company added to its marketed product portfolio by acquiring Karbinal™ ER, AcipHex® Sprinkle™, Cefaclor for Oral Suspension, and Flexichamber™.

For more information about Cerecor, please visit www.cerecor.com .

Forward-Looking Statements

This press release may include forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to significant risks and uncertainties that are subject to change based on various factors (many of which are beyond Cerecor’s control), which could cause actual results to differ from the forward-looking statements. Such statements may include, without limitation, statements with respect to Cerecor’s plans, objectives, projections, expectations and intentions and other statements identified by words such as “projects,” “may,” “will,” “could,” “would,” “should,” “continue,” “seeks,” “aims,” “predicts,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential,” or similar expressions (including their use in the negative), or by discussions of future matters such as: the development of product candidates or products, potential attributes and benefits of product candidates, the expansion of Cerecor’s drug portfolio, Cerecor’s ability to identify new indications for its current portfolio, and new product candidates that could be in-licensed, and other statements that are not historical. These statements are based upon the current beliefs and expectations of Cerecor’s management but are subject to significant risks and uncertainties, including: reliance on key personnel, including Mr. Greenleaf; risks associated with acquisitions, including the need to quickly and successfully integrate acquired assets and personnel; drug development costs, timing and other risks; Cerecor’s cash position and the potential need for it to raise additional capital; and those other risks detailed in Cerecor’s filings with the Securities and Exchange Commission. Actual results may differ from those set forth in the forward-looking statements. Except as required by applicable law, Cerecor expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Cerecor’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

For media and investor inquiries Maggie Beller Russo Partners LLC Maggie.Beller@RussoPartnersLLC.com 646-942-5631

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 0

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 156

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 395

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 145

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 53

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 184

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 275

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 22

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 385

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 149

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Wells Fargo's Insight on Industrial Stocks Amid Elections

Updated Category News Views 231

Wells Fargo's Industrial Sector Election Guide As the US presidential election approaches, Wells Fargo has closely examined the Industrials sector, pinpointing potential winners and those stocks that may face challenges. This analysis is particularly noteworthy given the significant changes in policy that may arise depending on the election outcome. Key Areas of Focus in...

Continue Reading
Woodward Secures Airbus Supplier Role for A350 Actuation System

Updated Category News Views 318

Woodward Partners with Airbus for A350 Spoiler Actuation Woodward, a prominent player in aerospace and energy control solutions, has been selected as a key supplier for Airbus's A350 Spoiler Actuation System. This collaboration marks another significant milestone in their long-standing relationship, demonstrating Woodward’s commitment to providing top-notch technology...

Continue Reading
GreenPower Motor Company Secures Significant Loan for Growth

Updated Category News Views 327

GreenPower Motor Company Announces Successful Loan Closure GreenPower Motor Company Inc. (NASDAQ: GP) has officially completed the third tranche of its secured term loan offering, securing an impressive aggregate principal amount of U.S. $300,000. The company specializes in designing and distributing all-electric, purpose-built, zero-emission vehicles tailored for various...

Continue Reading
Carrier Global's Strategic Moves to Enhance Market Growth

Updated Category News Views 383

Understanding Carrier Global's Transformation Journey Carrier Global Corporation (NYSE: CARR) is a leading entity in the heating, ventilation, and air conditioning (HVAC) industry, known for its ongoing transformation since its spin-off in 2020. This article delves into the company’s strategic maneuvers, financial trajectory, and competitive positioning to inform...

Continue Reading
International School of Permanent Makeup Enhances Education Offerings

Updated Category News Views 252

International School of Permanent Makeup Unveils New Website The International School of Permanent Makeup (ISPMU) has officially launched its redesigned website, providing an updated platform for aspiring beauty professionals to explore advanced certification courses. This move reflects ISPMU's commitment to delivering top-quality education in the permanent makeup field....

Continue Reading